Am J Perinatol 2004; 21(7): 383-386
DOI: 10.1055/s-2004-835307
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

Differential Clinical Manifestations of Congenital Cytomegalovirus Infection between Dizygotic Twins: A Case Report

Kei Kawana1 , Masahiro Nakayama2 , Toshiharu Yasugi1 , Mizuho Ishiwata1 , Genzo Marumo1 , Masato Sakai3 , Toshikazu Takeshima2 , Shiro Kozuma1 , Osamu Tsutsumi1 , Yuji Taketani1
  • 1Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo, Bunkyo-ku, Tokyo, Japan
  • 2Department of Pathology and Environmental Medicine, Osaka Medical Center and Research Institute for Maternal and Child Health, Izumi, Osaka, Japan
  • 3Aiiku Hospital, Minato-ku, Tokyo, Japan
Further Information

Publication History

Publication Date:
08 October 2004 (online)

To understand a mechanism for the difference in clinical manifestations of congenital cytomegalovirus (CMV) infection between dizygotic twins, the placentas of the dizygotic twins were evaluated for the number of the cells infected with CMV by immunohistochemical and in situ hybridization studies. A Japanese woman with dizygotic twin pregnancy had immunoglobulin M antibodies to CMV at 15 weeks gestation. Intrauterine growth retardation was noted only in the first twin. At birth, CMV was isolated from urine culture in both twins. Clinical manifestations for CMV, such as petechiae, jaundice, hepatosplenomegaly, and deafness were more pronounced in the first twin than in the second twin. Immunohistochemical and in situ hybridization studies showed CMV-positive cells two or three times more densely distributed in the placenta of the first twin compared with the second twin. These data suggest the severity of CMV manifestations of dizygotic twins may be in accord with the number of CMV-positive cells in the placenta.

REFERENCES

  • 1 Ahlfors K, Ivarsson S A, Nilsson H. On the unpredictable development of congenital cytomegalovirus infection. A study in twins.  Early Hum Dev. 1988;  18 125-135
  • 2 Ozono K, Mushiake S, Takeshima T, Nakayama M. Diagnosis of congenital cytomegalovirus infection by examination of placenta: application of polymerase chain reaction and in situ hybridization.  Pediatr Pathol Lab Med. 1997;  17 249-258
  • 3 Amirhessami-Aghili N, Manalo P, Hall M R, Tibbitts F D, Ort C A, Afsari A. Human cytomegalovirus infection of human placental explants in culture: histologic and immunohistochemical studies.  Am J Obstet Gynecol. 1987;  156 1365-1374
  • 4 Yamaguchi Y, Hironaka T, Kajiwara M, Tateno E, Kita H, Hirai K. Increased sensitivity for detection of human cytomegalovirus in urine by removal of inhibitors for the polymerase chain reaction.  J Virol Methods. 1992;  37 209-218
  • 5 Weiss L M, Movahed L A, Berry G J, Billingham M E. In situ hybridization studies for viral nucleic acids in heart and lung allograft biopsies.  Am J Clin Pathol. 1990;  93 714-716
  • 6 Muhlemann K, Miller R K, Metlay L, Menegus M A. Cytomegalovirus infection of the human placenta: an immunocytochemical study.  Hum Pathol. 1992;  23 1234-1237
  • 7 Sinzger C, Muntefering H, Loning T, Stoss H, Placher B, Jahn G. Cell types infected in human cytomegalovirus placentitis identified by immunohistochemical double staining.  Virchows Arch A Pathol Anat Histopathol. 1993;  423 249-256
  • 8 Fisher G, Genbacev O, Maidji E, Pereira L. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis.  J Virol. 2000;  74 6808-6820

Kei KawanaM.D. Ph.D. 

Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo

7-3-1 Hongo, Bunkyo-ku, 113-8655 Tokyo, Japan

    >